Novigenix SA

📍 Lausanne, Switzerland🗓 Founded 2014👥 27 employees💰 Last funded 2022
Biotechnology🌐 novigenix.com
Website LinkedIn
Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes. The Novigenix proprietary LITOseek platform is optimized for mapping the response of the immune system to onset and progression of disease by integrating patient multi-omics data, advanced Machine Learning, and artificial intelligence approaches, to provide actionable insights and precision solutions for optimization of patient’s therapeutic journey. Our product pipeline currently includes patient stratification solutions in the field of Immuno-Oncology, Colorectal Cancer early detection and recurrence monitoring, and therapy optimization solutions for management of cancer patients. Novigenix provides services to Pharma and Biotech customers by leveraging the proprietary LITOseek data analytics and patient clinical data platform to deliver previously unknown insights into the immune system, and develop ImmunoTranscriptomic solutions with actionable biomarkers for optimization of new therapeutic modalities. Specialties Precision Medicine solutions in oncology and other indications, ImmunoTranscriptomics, Machine Learning and Artificial Intelligence, clinical development of multi-omics biomarkers, standardized RNAseq platform and analytic pipelines, product development for In-vitro Diagnostics and Liquid Biopsy solutions.
3
Total investors
0
Early stage
2
Mid stage
1
Late stage
2014
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Switzerland
2
Investor activity2018–2022 · investors recorded per year
201812019120221
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Novigenix SA?
Novigenix SA has 3 investors on record on gritt.io, 2 mid-stage and 1 late-stage investors.
When did Novigenix SA last raise funding?
The most recent investment in Novigenix SA recorded on gritt.io was in 2022.
When was Novigenix SA founded?
Novigenix SA was founded in 2014.
What industry is Novigenix SA in?
Novigenix SA operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Novigenix SA based?
Novigenix SA is headquartered in Lausanne, Switzerland.